D-BACE in Combination With Chemotherapy and Carelizumab for Resectable II-IIIA or Potentially Resectable T3-4N2 Stage IIIB NSCLC

Clinical trial NCT07016126 · RECRUITING

Trial details

NCT number: NCT07016126
Sponsor: Guangdong Provincial People's Hospital
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

NSCLC (Non-small Cell Lung Cancer)

Start date: 2024-12-22
Primary completion: 2027-12-22
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.